Sun Life Financial INC raised its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 63,362.5% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,077 shares of the medical instruments supplier’s stock after buying an additional 5,069 shares during the period. Sun Life Financial INC’s holdings in DENTSPLY SIRONA were worth $330,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently bought and sold shares of XRAY. UBS Asset Management Americas Inc. increased its holdings in shares of DENTSPLY SIRONA by 4.1% in the first quarter. UBS Asset Management Americas Inc. now owns 1,024,996 shares of the medical instruments supplier’s stock valued at $64,001,000 after buying an additional 40,816 shares in the last quarter. Raymond James Financial Services Advisors Inc. bought a new position in shares of DENTSPLY SIRONA in the first quarter valued at $822,000. Nordea Investment Management AB increased its holdings in shares of DENTSPLY SIRONA by 1.4% in the first quarter. Nordea Investment Management AB now owns 10,160 shares of the medical instruments supplier’s stock valued at $634,000 after buying an additional 137 shares in the last quarter. Aberdeen Asset Management PLC UK increased its holdings in shares of DENTSPLY SIRONA by 4.2% in the first quarter. Aberdeen Asset Management PLC UK now owns 43,754 shares of the medical instruments supplier’s stock valued at $2,732,000 after buying an additional 1,778 shares in the last quarter. Finally, Cipher Capital LP bought a new position in shares of DENTSPLY SIRONA in the first quarter valued at $467,000. 93.87% of the stock is currently owned by institutional investors.

Shares of DENTSPLY SIRONA Inc. (XRAY) traded up 0.98% during mid-day trading on Friday, reaching $59.81. 1,103,503 shares of the company’s stock traded hands. DENTSPLY SIRONA Inc. has a 52 week low of $52.54 and a 52 week high of $65.68. The firm’s market cap is $13.73 billion. The company’s 50 day moving average is $56.98 and its 200-day moving average is $61.67.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.65. The company had revenue of $992.70 million for the quarter, compared to analyst estimates of $1 billion. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The business’s revenue for the quarter was down 2.9% compared to the same quarter last year. During the same period last year, the business posted $0.76 earnings per share. Equities analysts expect that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Sun Life Financial INC Boosts Holdings in DENTSPLY SIRONA Inc. (XRAY)” was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another website, it was stolen and republished in violation of United States & international copyright & trademark legislation. The correct version of this story can be accessed at https://www.watchlistnews.com/sun-life-financial-inc-boosts-holdings-in-dentsply-sirona-inc-xray/1601373.html.

XRAY has been the topic of several research reports. Stifel Nicolaus reaffirmed a “buy” rating and issued a $66.00 price target (down previously from $70.00) on shares of DENTSPLY SIRONA in a report on Thursday, August 10th. Zacks Investment Research raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price target on the stock in a report on Thursday, July 13th. HC Wainwright initiated coverage on DENTSPLY SIRONA in a report on Tuesday, July 11th. They issued a “buy” rating and a $74.00 price target on the stock. BidaskClub raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, June 30th. Finally, Jefferies Group LLC dropped their price target on DENTSPLY SIRONA from $72.00 to $66.00 and set a “buy” rating on the stock in a report on Wednesday, August 23rd. Three analysts have rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the stock. DENTSPLY SIRONA has a consensus rating of “Hold” and a consensus target price of $65.80.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.